首页> 外文期刊>Seminars in dialysis >A challenge for nephrologists--increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States.
【24h】

A challenge for nephrologists--increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States.

机译:肾病学家面临的挑战-在美国增加瘘管成熟率,减少瘘管成熟时间并降低透析导管患病率。

获取原文
获取原文并翻译 | 示例
           

摘要

Tunneled dialysis catheters are simultaneously a benefit and burden for hemodialysis patients. The infectious and vascular complications of catheters are well documented. Despite this, prevalence of catheter use in the US hemodialysis population remains high and could be due in part to increased efforts to create arteriovenous (AV) fistulas in most new end-stage renal disease patients. The editorial argues that creating fistulas instead of prosthetic grafts is the correct approach and that inadequately diagnosed and treated primary fistula failure is a major cause of excessive and prolonged catheter dependency. An understanding of AV fistula physiology and the treatable causes of primary fistula failure are key to maximizing the percentage of created fistulas that are successfully used for dialysis. Diagnosis of fistula malfunction based on history, physical examination, and hemodynamic and angiographic evaluation is discussed, and treatment strategies presented. A major emphasis is placed on early primary fistula failure recognition and intervention. It is the author's contention if adequate vein and artery are selected for initial fistula construction nearly all fistulas should eventually function adequately to support dialysis and sooner than previously appreciated by utilizing an array of percutaneous and surgical therapies. Fistula malfunction is a unique problem within the spectrum of vascular disease and therefore demands that patients are treated by physicians with demonstrated expertise and experience.
机译:隧道式透析导管同时是血液透析患者的利益和负担。导管的感染和血管并发症已得到充分证明。尽管如此,在美国血液透析人群中使用导管的患病率仍然很高,这可能部分是由于在大多数新的终末期肾病患者中加大了动静脉瘘的制造力度所致。社论认为,用瘘管代替假体移植是正确的方法,诊断和治疗不充分的原发性瘘管衰竭是过度和长期依赖导管的主要原因。了解AV瘘生理和原发性瘘管失败的可治疗原因是最大程度地增加成功用于透析的造瘘百分比的关键。讨论了基于病史,体格检查以及血液动力学和血管造影评估的瘘管功能不全的诊断,并提出了治疗策略。主要重点在于早期原发性瘘管衰竭的识别和干预。如果为初期瘘管的构建选择足够的静脉和动脉,几乎所有的瘘管都应最终发挥足够的功能来支持透析,并且比以前通过使用一系列经皮和外科疗法早日意识到,这是作者的争论。瘘管功能失调是血管疾病范围内的一个独特问题,因此要求患者由经验丰富的医师治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号